Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1967 Jul 1;126(1):149-58.
doi: 10.1084/jem.126.1.149.

Generation of chemotactic activity in rabbit serum by plasminogen-streptokinase mixtures

Generation of chemotactic activity in rabbit serum by plasminogen-streptokinase mixtures

F B Taylor Jr et al. J Exp Med. .

Abstract

The addition of plasminogen and streptokinase to rabbit serum results in appearance of chemotactic activity which is relatively heat-labile and dialyzable. Generation of this activity requires heat-labile factors in serum, but not the sixth component of complement. The optimal mole ratio for generation of chemotactic activity is 1:1 to 1:3 for plasminogen to streptokinase. Neither material alone is sufficient to generate the activity in fresh serum. Generation of chemotactic activity can be blocked by the presence of epsilon-aminocaproic acid. This plasmin-generated chemotactic factor sediments slowly in a sucrose density gradient during ultracentrifugation. The addition of plasminogen and streptokinase to rabbit serum containing the preformed chemotactic factor (activated trimolecular complex of C'5, C'6, C'7) causes destruction of the chemotactic factor and loss of hemolytic activity of the sixth component of complement. The same mole ratio of reactants for optimal expression of the phenomenon holds as for plasmin generation of chemotactic activity in untreated serum.

PubMed Disclaimer

References

    1. Immunology. 1966 Aug;11(2):141-53 - PubMed
    1. J Exp Med. 1958 Mar 1;107(3):451-74 - PubMed
    1. J Biol Chem. 1964 Aug;239:2651-6 - PubMed
    1. J Exp Med. 1965 Aug 1;122:327-46 - PubMed